Skip to main navigation menu Skip to main content Skip to site footer
English | Spanish
Editorial
Revistas / Journals
Salud, Ciencia y Tecnología Metaverse Basic and Applied Research Data & Metadata Interdisciplinary Rehabilitation Salud, Ciencia y Tecnología - Serie de Conferencias Community and Interculturality in Dialogue Seminars in Medical Writing and Education Health Leadership and Quality of Life Gamification and Augmented Reality Southern perspective / Perspectiva austral
Current Archives
About
About the Journal Submissions Editorial Team Privacy Statement Contact
×
English | Spanish
Editorial

Salud, Ciencia y Tecnología Metaverse Basic and Applied Research Data & Metadata Interdisciplinary Rehabilitation Salud, Ciencia y Tecnología - Serie de Conferencias Community and Interculturality in Dialogue Seminars in Medical Writing and Education Health Leadership and Quality of Life Gamification and Augmented Reality Southern perspective / Perspectiva austral
Current Archives

About the Journal Submissions Editorial Team Privacy Statement Contact
Review
Published: 2024-06-12
DOI: https://doi.org/10.56294/piii2024355

Association between levodopa administration and melanoma: A systematic review

By
Fernanda Luparelli Mello ,
Fernanda Luparelli Mello

Facultad de Medicina y Ciencias de la Salud - Universidad Abierta Interamericana

Search this author on:

PubMed | Google Scholar
Marcelo Adrian Estrin ,
Marcelo Adrian Estrin

Facultad de Medicina y Ciencias de la Salud - Universidad Abierta Interamericana

Search this author on:

PubMed | Google Scholar

Abstract

Introduction: Parkinson's disease (PD) is a neurodegenerative disease and levodopa is the main drug used in the treatment of this disease. A study conducted in Denmark demonstrated a two-fold higher incidence of malignant melanoma in patients with Parkinson's, but no correlation was found between levodopa treatment and this incidence. Material and methods: The present systematic review used search engines such as pubmed and Google academic to search for articles of the clinical and randomized trial type. Results: The results of the systematic review indicate a complexity in the relationship between levodopa administration, Parkinson's disease, and melanoma risk. The evidence reviewed suggests that levodopa does not appear to be a significant causal factor in the development of melanoma in patients with Parkinson's disease. Despite the problems raised, the well-established therapeutic benefits of levodopa in the management of the symptoms of Parkinson's disease continue to outweigh the potential risk of causing melanoma. Conclusion: The study concludes that there is an increased risk of developing melanoma in patients with Parkinson's disease but that there is no evidence of a causal role of levodopa in increasing this risk or accelerating its growth

Keywords:

Parkinson,
levodopa,
melanoma,
skin,
disease and skin,

How to Cite

1.
Luparelli Mello F, Estrin MA. Association between levodopa administration and melanoma: A systematic review . SCT Proceedings in Interdisciplinary Insights and Innovations [Internet]. 2024 Jun. 12 [cited 2024 Jul. 5];2:355. Available from: https://proceedings.saludcyt.ar/index.php/piii/article/view/355

Copyright Notice

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Vol. 2 (2024)
See full issue

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.